Artios raised €29M in a Series A round in Sep 2016. The company is based in Cambridge, UK. Investors in the round: Abbvie Biotech Ventures, Imperial Innovations Limited, SV Life Sciences. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
